Disaccharide inflammation inhibitors and uses thereof
    3.
    发明授权
    Disaccharide inflammation inhibitors and uses thereof 失效
    二糖类炎症抑制剂及其用途

    公开(公告)号:US5639734A

    公开(公告)日:1997-06-17

    申请号:US359582

    申请日:1994-12-20

    CPC分类号: C07H15/18 C07H15/203

    摘要: The present invention provides a composition of matter comprising a biosynthetic anti-inflammatory oligosaccharide, comprising the structure of: sugar - sugar - X - R; wherein said sugar is selected from the group consisting of N-acetylneuraminic acid, galactose, N-acetylglucosamine, N-acetylgalactosamine, fucose and mannose; wherein X is a bridging atom selected from the group consisting of oxygen, sulfur, nitrogen and carbon; and wherein R is an aglycone selected from the group consisting of naphthol, naphthalenemethane, indenol, a heterocyclic derivative of indenol, a heterocyclic derivative of naphthol and a heterocyclic derivative of naphthalenemethanol. Also provided is a method of treating an inflammatory disease in an individual comprising the step of administering to said individual a therapeutically effective dose of the novel composition of the present invention.

    摘要翻译: 本发明提供了包含生物合成抗炎寡糖的物质组合物,其包含以下结构:糖 - 糖-X-R; 其中所述糖选自N-乙酰神经氨酸,半乳糖,N-乙酰葡糖胺,N-乙酰半乳糖胺,岩藻糖和甘露糖; 其中X是选自氧,硫,氮和碳的桥连原子; 并且其中R是选自萘酚,萘甲烷,茚醇,茚醇的杂环衍生物,萘酚的杂环衍生物和萘甲醇的杂环衍生物的糖苷配基。 还提供了治疗个体炎性疾病的方法,包括向所述个体施用治疗有效剂量的本发明的新型组合物的步骤。

    Heparan sulfate biosynthesis primers
    4.
    发明授权
    Heparan sulfate biosynthesis primers 失效
    硫酸肝素生物合成引物

    公开(公告)号:US5104856A

    公开(公告)日:1992-04-14

    申请号:US611255

    申请日:1990-11-09

    IPC分类号: A61K31/58 A61K31/70

    CPC分类号: A61K31/58 A61K31/70

    摘要: Conjugates of .beta.-D-xylose with estrogens or modified forms of estrogens are effective in stimulating the synthesis of heparan sulfate, and inhibiting the production of proteoglycan in animal subjects. Accordingly, these conjugates are useful in treating conditions where antithrombotic or antiproliferative activity is desirable.

    摘要翻译: β-D-木糖与雌激素或修饰形式的雌激素的缀合物有效刺激硫酸乙酰肝素的合成,并抑制动物受试者中蛋白多糖的产生。 因此,这些缀合物可用于治疗需要抗血栓形成或抗增殖活性的病症。